TNFRSF6B and neoplasm: IHC analysis verified DcR3 expression in oral cancer cells in the PDTX and SAS xenograft models, and we observed that DcR3 expression was decreased after TPL administrated in clinical tumor tissue‐bearing mice when compared with the controls (Figure 3D).